Antabio SAS
7Patents
7Active
7Granted
45Portfolio score
Filing activity: Jun 12, 2014 → Nov 15, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11000511B2 | Chemical compounds as antibiotics | Chemistry; Metallurgy | 1 | Active |
| US11905286B2 | Diazabicyclooctanones as inhibitors of serine beta-lactamases | Chemistry; Metallurgy | 1 | Active |
| US12286411B2 | Indane derivatives for use in the treatment of bacterial infection | Chemistry; Metallurgy | 0 | Active |
| US12378244B2 | Diazabicyclooctanones as inhibitors of serine β-lactamases | Emerging Cross-Sectional Technologies | 0 | Active |
| US12247013B2 | Indane derivatives for use in the treatment of bacterial infection | Chemistry; Metallurgy | 0 | Active |
| US9914712B2 | Antibacterial thiazolecarboxylic acids | Chemistry; Metallurgy | 0 | Active |
| US11299467B2 | Chemical compounds | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.